NR602 PRIMARY CARE OF THE CHILDBEARING FAMILY
MIDTERM REVIEW / 100 WOMEN'S HEALTH QUESTIONS
WITH VERIFIED ANSWERS & RATIONALES
CORE DOMAINS
Well-Woman Care and Preventive Screening
Contraception and Family Planning
Sexually Transmitted Infections and Reproductive Tract Infections
Abnormal Uterine Bleeding and Menstrual Disorders
Menopause and Hormone Therapy
Breast Health and Common Breast Disorders
Pelvic Floor Disorders and Urogynecology
Pregnancy and Antepartum Care
Cultural Competence and Patient Education
INTRODUCTION
This comprehensive examination assesses the women's health knowledge
and clinical decision-making skills required of the family nurse practitioner.
It evaluates foundational well-woman care, contraception management, STI
diagnosis and treatment, menstrual disorders, menopause management,
and antepartum assessment. The examination employs multiple-choice
and scenario-based questions to simulate realistic primary care
encounters. Emphasis is placed on critical thinking, evidence-based
screening guidelines, pharmacologic and non-pharmacologic management,
and patient-centered communication. This assessment prepares
candidates for the rigor of advanced practice certification and real-world
clinical practice.
SECTION ONE: QUESTIONS 1–100
1. According to the 2024 USPSTF updated guidelines, what is the
recommended age to begin screening mammography for average-risk
women, and what is the screening interval?
A. Age 50, biennially
B. Age 40, annually
,C. Age 45, annually
D. Age 40, biennially
D. Age 40, biennially
RATIONALE: The USPSTF updated their guidelines in 2024 to
recommend that women at average risk for breast cancer initiate screening
mammography at age 40 and continue every two years until age 74. This is
a shift from the previous recommendation of starting at age 50.
2. A 26-year-old female presents for her well-woman exam. According
to the latest ASCCP guidelines, what is the preferred method for
cervical cancer screening in this patient?
A. Pap smear alone
B. Primary HPV testing alone
C. Co-testing with Pap smear and HPV
D. No screening is needed until age 30
A. Pap smear alone
RATIONALE: For individuals aged 21 to 24, cytology (Pap smear) alone
is the recommended screening method. Primary HPV testing alone is
preferred for individuals aged 25 to 29, and co-testing is preferred for
individuals aged 30 to 65.
3. A 35-year-old female undergoes cervical cancer screening. Her Pap
smear shows Low-Grade Squamous Intraepithelial Lesion (LSIL), and
her HPV test is positive for HPV 16. What is the recommended
management based on ASCCP risk-based management guidelines?
A. Repeat co-testing in 12 months
B. Colposcopy
C. Repeat Pap smear in 6 months
D. Treatment with cryotherapy immediately
B. Colposcopy
RATIONALE: Under the 2019 ASCCP risk-based management
guidelines, a finding of LSIL with a positive HPV 16 or 18 result places the
,patient in an immediate colposcopy management pathway due to the high-
risk nature of these specific HPV genotypes.
4. A 24-year-old patient presents for a routine reproductive-health
visit. She reports regular 28-day menstrual cycles. Which finding
represents the most likely time of ovulation?
A. Approximately day 5
B. Approximately day 10
C. Approximately day 14
D. Approximately day 25
C. Approximately day 14
RATIONALE: In a typical 28-day cycle, ovulation occurs approximately
14 days before the next menstrual period, commonly around day 14. The
follicular phase varies more than the luteal phase.
5. Which hormone is primarily responsible for maintaining the
endometrial lining during the luteal phase?
A. Follicle-stimulating hormone
B. Luteinizing hormone
C. Estrogen
D. Progesterone
D. Progesterone
RATIONALE: After ovulation, the corpus luteum produces
progesterone. Progesterone stabilizes and prepares the endometrium for
possible implantation and supports early pregnancy until placental hormone
production becomes established.
6. A patient wants to prevent pregnancy and asks about highly
effective reversible contraception. Which option is classified as a
long-acting reversible contraceptive?
A. Combined oral contraceptive
B. Condoms
, C. Intrauterine device
D. Fertility-awareness method
C. Intrauterine device
RATIONALE: Intrauterine devices and contraceptive implants are long-
acting reversible contraceptives. They provide highly effective pregnancy
prevention without requiring daily adherence.
7. Which history finding is most important before prescribing an
estrogen-containing combined hormonal contraceptive?
A. Seasonal allergies
B. Migraine with aura
C. Occasional dysmenorrhea
D. Family history of acne
B. Migraine with aura
RATIONALE: Estrogen-containing contraception is generally avoided in
patients with migraine with aura because of the increased risk of ischemic
stroke. A careful cardiovascular and thrombotic-risk history is essential
before prescribing estrogen-containing methods.
8. A patient taking combined oral contraceptives asks what to do if
she misses one active pill. What is the best general counseling?
A. Permanently discontinue the medication
B. Take the missed pill as soon as remembered and continue the schedule
C. Skip the remainder of the pack
D. Double every remaining dose
B. Take the missed pill as soon as remembered and continue the
schedule
RATIONALE: For a single missed active pill, the patient should take it
as soon as remembered and continue the remaining pills on schedule.
Backup contraception is generally not required for one missed pill.
9. A 28-year-old G2P1 presents at 12 weeks gestation for her first
prenatal visit. She reports mild nausea and has a BMI of 32. Her last
MIDTERM REVIEW / 100 WOMEN'S HEALTH QUESTIONS
WITH VERIFIED ANSWERS & RATIONALES
CORE DOMAINS
Well-Woman Care and Preventive Screening
Contraception and Family Planning
Sexually Transmitted Infections and Reproductive Tract Infections
Abnormal Uterine Bleeding and Menstrual Disorders
Menopause and Hormone Therapy
Breast Health and Common Breast Disorders
Pelvic Floor Disorders and Urogynecology
Pregnancy and Antepartum Care
Cultural Competence and Patient Education
INTRODUCTION
This comprehensive examination assesses the women's health knowledge
and clinical decision-making skills required of the family nurse practitioner.
It evaluates foundational well-woman care, contraception management, STI
diagnosis and treatment, menstrual disorders, menopause management,
and antepartum assessment. The examination employs multiple-choice
and scenario-based questions to simulate realistic primary care
encounters. Emphasis is placed on critical thinking, evidence-based
screening guidelines, pharmacologic and non-pharmacologic management,
and patient-centered communication. This assessment prepares
candidates for the rigor of advanced practice certification and real-world
clinical practice.
SECTION ONE: QUESTIONS 1–100
1. According to the 2024 USPSTF updated guidelines, what is the
recommended age to begin screening mammography for average-risk
women, and what is the screening interval?
A. Age 50, biennially
B. Age 40, annually
,C. Age 45, annually
D. Age 40, biennially
D. Age 40, biennially
RATIONALE: The USPSTF updated their guidelines in 2024 to
recommend that women at average risk for breast cancer initiate screening
mammography at age 40 and continue every two years until age 74. This is
a shift from the previous recommendation of starting at age 50.
2. A 26-year-old female presents for her well-woman exam. According
to the latest ASCCP guidelines, what is the preferred method for
cervical cancer screening in this patient?
A. Pap smear alone
B. Primary HPV testing alone
C. Co-testing with Pap smear and HPV
D. No screening is needed until age 30
A. Pap smear alone
RATIONALE: For individuals aged 21 to 24, cytology (Pap smear) alone
is the recommended screening method. Primary HPV testing alone is
preferred for individuals aged 25 to 29, and co-testing is preferred for
individuals aged 30 to 65.
3. A 35-year-old female undergoes cervical cancer screening. Her Pap
smear shows Low-Grade Squamous Intraepithelial Lesion (LSIL), and
her HPV test is positive for HPV 16. What is the recommended
management based on ASCCP risk-based management guidelines?
A. Repeat co-testing in 12 months
B. Colposcopy
C. Repeat Pap smear in 6 months
D. Treatment with cryotherapy immediately
B. Colposcopy
RATIONALE: Under the 2019 ASCCP risk-based management
guidelines, a finding of LSIL with a positive HPV 16 or 18 result places the
,patient in an immediate colposcopy management pathway due to the high-
risk nature of these specific HPV genotypes.
4. A 24-year-old patient presents for a routine reproductive-health
visit. She reports regular 28-day menstrual cycles. Which finding
represents the most likely time of ovulation?
A. Approximately day 5
B. Approximately day 10
C. Approximately day 14
D. Approximately day 25
C. Approximately day 14
RATIONALE: In a typical 28-day cycle, ovulation occurs approximately
14 days before the next menstrual period, commonly around day 14. The
follicular phase varies more than the luteal phase.
5. Which hormone is primarily responsible for maintaining the
endometrial lining during the luteal phase?
A. Follicle-stimulating hormone
B. Luteinizing hormone
C. Estrogen
D. Progesterone
D. Progesterone
RATIONALE: After ovulation, the corpus luteum produces
progesterone. Progesterone stabilizes and prepares the endometrium for
possible implantation and supports early pregnancy until placental hormone
production becomes established.
6. A patient wants to prevent pregnancy and asks about highly
effective reversible contraception. Which option is classified as a
long-acting reversible contraceptive?
A. Combined oral contraceptive
B. Condoms
, C. Intrauterine device
D. Fertility-awareness method
C. Intrauterine device
RATIONALE: Intrauterine devices and contraceptive implants are long-
acting reversible contraceptives. They provide highly effective pregnancy
prevention without requiring daily adherence.
7. Which history finding is most important before prescribing an
estrogen-containing combined hormonal contraceptive?
A. Seasonal allergies
B. Migraine with aura
C. Occasional dysmenorrhea
D. Family history of acne
B. Migraine with aura
RATIONALE: Estrogen-containing contraception is generally avoided in
patients with migraine with aura because of the increased risk of ischemic
stroke. A careful cardiovascular and thrombotic-risk history is essential
before prescribing estrogen-containing methods.
8. A patient taking combined oral contraceptives asks what to do if
she misses one active pill. What is the best general counseling?
A. Permanently discontinue the medication
B. Take the missed pill as soon as remembered and continue the schedule
C. Skip the remainder of the pack
D. Double every remaining dose
B. Take the missed pill as soon as remembered and continue the
schedule
RATIONALE: For a single missed active pill, the patient should take it
as soon as remembered and continue the remaining pills on schedule.
Backup contraception is generally not required for one missed pill.
9. A 28-year-old G2P1 presents at 12 weeks gestation for her first
prenatal visit. She reports mild nausea and has a BMI of 32. Her last
